Tevogen Bio Holdings (TVGN) Receivables - Other (2023 - 2026)
Tevogen Bio Holdings (TVGN) reported Receivables - Other of $158819.0 for Q1 2026, little changed on a YoY basis from $158819.0 in Q1 2025, and little changed quarter-over-quarter from $158819.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Receivables - Other for 4 years, with the latest figure at $158819.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other changed 0.0% year-over-year to $158819.0; the trailing twelve-month figure through Mar 2026 stood at $158819.0 (changed 0.0% YoY), and the FY2025 full-year result was $158819.0, changed 0.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $158819.0, roughly flat from $158819.0 in the prior quarter.
- The five-year high for Receivables - Other was $344500.0 in Q4 2023, with the low at $158819.0 in Q1 2024.
- Historically, Receivables - Other has averaged $177387.1 across 4 years, with a median of $158819.0 in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Other sank 53.9% — and 2025, when it changed 0.0%.
- Tevogen Bio Holdings' Receivables - Other stood at $344500.0 in 2023, then slumped by 53.9% to $158819.0 in 2024, then changed by 0.0% to $158819.0 in 2025, then changed by 0.0% to $158819.0 in 2026.
- The last three Receivables - Other figures came in at $158819.0 (Q1 2026), $158819.0 (Q4 2025), and $158819.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,819.00 |
| Mar 31, 2026 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Dec 31, 2023 | 344,500.00 |
| Dec 31, 2023 | 344,500.00 |